The coexistence of gout and psoriatic disease (PD) is increasingly recognized in clinical practice, with overlapping phenotypes and shared comorbidities complicating diagnosis and treatment decisions.
The coexistence of gout and psoriatic disease (PD) is increasingly recognized in clinical practice, with overlapping phenotypes and shared comorbidities complicating diagnosis and treatment decisions.
Patients with gout who achieved serum urate levels below 6 mg/dL within 12 months of starting urate-lowering therapy (ULT) had a lower 5-year risk of major adverse cardiovascular events compared with those who did not reach target, according...
Patients with gout who achieved serum urate levels below 6 mg/dL within 12 months of starting urate-lowering therapy (ULT) had a lower 5-year risk of major adverse cardiovascular events compared with those who did not reach target, according...
Patients with gout are significantly more likely to receive long-term opioid prescriptions compared with individuals without gout, according to a large matched cohort study using national Veterans Health Administration data.
Patients with gout are significantly more likely to receive long-term opioid prescriptions compared with individuals without gout, according to a large matched cohort study using national Veterans Health Administration data.
Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Three screening questionnaires were assessed for sensitivity and specificity in identifying undiagnosed psoriatic arthritis among patients with psoriasis.
Three screening questionnaires were assessed for sensitivity and specificity in identifying undiagnosed psoriatic arthritis among patients with psoriasis.
A novel magnetic resonance imaging categorization system improved interpretation consistency between clinicians and radiologists, possibly enhancing the accuracy of clinical decision-making.
A novel magnetic resonance imaging categorization system improved interpretation consistency between clinicians and radiologists, possibly enhancing the accuracy of clinical decision-making.
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...